121 related articles for article (PubMed ID: 10707571)
1. [Insulin sensitizer and urate metabolism].
Iwatani M; Wasada T; Iwamoto Y; Kamatani N
Nihon Rinsho; 2000 Feb; 58(2):430-4. PubMed ID: 10707571
[TBL] [Abstract][Full Text] [Related]
2. The role of troglitazone in treating the insulin resistance syndrome.
Granberry MC; Schneider EF; Fonseca VA
Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
[TBL] [Abstract][Full Text] [Related]
3. [Uric acid metabolism and insulin resistance in type 2 diabetes].
Wasada T; Iwatani M
Nihon Rinsho; 2002 Aug; 60 Suppl 8():167-72. PubMed ID: 12355741
[No Abstract] [Full Text] [Related]
4. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular effects of the thiazolidinedione troglitazone].
Yamada K; Kuzuya H; Nakano T
Nihon Rinsho; 2000 Feb; 58(2):435-9. PubMed ID: 10707572
[TBL] [Abstract][Full Text] [Related]
6. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent.
Tsunoda S; Kamide K; Minami J; Kawano Y
Am J Hypertens; 2002 Aug; 15(8):697-701. PubMed ID: 12160192
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones, dyslipidaemia and insulin resistance syndrome.
Sunayama S; Watanabe Y; Daida H; Yamaguchi H
Curr Opin Lipidol; 2000 Aug; 11(4):397-402. PubMed ID: 10945722
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance syndrome: options for treatment.
Granberry MC; Fonseca VA
South Med J; 1999 Jan; 92(1):2-15. PubMed ID: 9932820
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Kitaoka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
[No Abstract] [Full Text] [Related]
11. [Insulin sensitizer drugs--review].
Yamanouchi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
[No Abstract] [Full Text] [Related]
12. "Glitazones", a prospect for non-insulin-dependent diabetes.
Petrie J; Small M; Connell J
Lancet; 1997 Jan; 349(9045):70-1. PubMed ID: 8996411
[No Abstract] [Full Text] [Related]
13. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Westerbacka J; Yki-Järvinen H
Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
[No Abstract] [Full Text] [Related]
14. [Insulin sensitizer. A new therapy option for type 2 diabetic patients].
Filz HP
MMW Fortschr Med; 2000 Sep; 142(38):31-3. PubMed ID: 11050888
[TBL] [Abstract][Full Text] [Related]
15. [Thiazolidinediones].
Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
[No Abstract] [Full Text] [Related]
16. Insulin resistance and the prevention of diabetes mellitus.
Keen H
N Engl J Med; 1994 Nov; 331(18):1226-7. PubMed ID: 7935664
[No Abstract] [Full Text] [Related]
17. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.
Mudaliar S; Henry RR
Annu Rev Med; 2001; 52():239-57. PubMed ID: 11160777
[TBL] [Abstract][Full Text] [Related]
18. Gout and Metabolic Syndrome: a Tangled Web.
Thottam GE; Krasnokutsky S; Pillinger MH
Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones--tools for the research of metabolic syndrome X.
Komers R; Vrána A
Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
[TBL] [Abstract][Full Text] [Related]
20. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
